Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Q-Med Aktiebolag
AB
Active
Org 5562586882
Seminariegatan 21, 752 28
Uppsala
Manufacture of basic pharmaceutical products
· NACE 2110
Est. 1985
589 employees
Watchlist
Share
Sweden
/
Companies
/
Manufacture of basic pharmaceutical products
/
Q-Med Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
JG
Jimmy Gustav Almqvist
Chief Auditor
Chief Auditor
2025
Former (2)
MK
Marc Karl-Gustaf Karlsson
Chief Auditor
Chief Auditor
2022 – 2025
HA
Håkan Anders Olsson Reising
Chief Auditor
Chief Auditor
2020 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
LP
Lars Pontus Rundström
Board of Directors
2025
SS
Scassellati Sforzolini Baldo
Board of Directors
2020
GE
Gunilla Elisabet Kovac
Board of Directors
2022
AP
Adrian Patrick Murphy
Chairman
2022
Former (6)
GM
Gurli Maria Helena Åsbrink
Board of Directors
2020 – 2021
AC
Alexandre Charles Brennan
Board of Directors
2020 – 2021
KE
Kim Erik Sandell
Board of Directors
2022 – 2025
CM
Cécile Martine Dussart
Chairman
2022 – 2022
EP
Erik Patrik Plöen
Chairman
2021 – 2022
PS
Patrick Scott Beringer
Chairman
2020 – 2021
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
GALDERMA PHARMA S.A.
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Q-Med Aktiebolag
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network